ISSN 2590-0048
Vol. 4, Issue 4, 2022August 30, 2022 CDT
Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective
Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective
Ahmad Ibrahim, Nabil Chamseddine, Jean El-cheikh, Colette Hanna, Walid Moukadem, Fady Nasr, Ahmad Younis, Ali Bazarbachi,
Articles in Vol. 4, Issue 4, 2022
Vol. 4, Issue 4, 2022
- ‘Standing on the Shoulders of the Giants’: Dr Rainer StorbMohamad MohtyRainer Storb
- Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and PerspectiveAhmad IbrahimNabil ChamseddineJean El-cheikhColette HannaWalid MoukademFady NasrAhmad YounisAli Bazarbachi
- Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) StudyAnn JanssensZwi N. BernemanFritz OffnerSylvia SnauwaertPhilippe MineurGaetan VanstraelenStef MeersIsabelle SpoormansDominique BronIsabelle Vande BroekCharlotte Van BogaertBirgit De BeleyrAnn SmetLasse NielsenRobert WapenaarMarc André
- Effects of Erythrocytapheresis Procedures on Delayed Bone Marrow Conversion in Sickle Cell DiseaseEmily PophamKaren MoellerAshok Raj
- Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case SeriesShamis KhanSara Taveras AlamRosa Torres RamosJohn Etumbani MbueEffrosyni ApostolidouGustavo A. RiveroSarvari Venkata Yellapragada
Ibrahim, Ahmad, Nabil Chamseddine, Jean El-cheikh, Colette Hanna, Walid Moukadem, Fady Nasr, Ahmad Younis, and Ali Bazarbachi. 2022. “Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective.” Clinical Hematology International 4 (4): 127–32. https://doi.org/10.1007/s44228-022-00017-3.